Zhong Lan Wei

Direttore/Membro del Consiglio presso ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.

44 anni

Health Technology

Profilo

Zhong Lan Wei currently works at Zhejiang Garden Biopharmaceutical Co., Ltd., as Vice Chairman from 2022 and Zhejiang Garden Pharmaceutical Co., Ltd., as Executive Director from 2021.

Posizioni attive di Zhong Lan Wei

Società	Posizione	Inizio
ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.	Direttore/Membro del Consiglio	19/04/2022
Zhejiang Garden Pharmaceutical Co., Ltd. Zhejiang Garden Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Garden Pharmaceutical Co., Ltd. is engaged in manufacture pharmaceutical products including Xinnaojian tablets, panaxnotoginseng capsules, sucralfate tablets and Lansoprazole.The company leading product is Xinnaojian traditional chinese tablet, it can be used in the therapy of cardiovascular and cerebrovascular diseases (high blood pressure, hyperlipemia) and cytopenia caused by the teletherapy and chemotherapy of tumor. The company was founded in August, 2001 and is headquartered in Dongyang China.	Direttore/Membro del Consiglio	29/09/2021

Tutte le posizioni attive di Zhong Lan Wei

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Zhong Lan Wei

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.	Health Technology

Aziende private	1
Zhejiang Garden Pharmaceutical Co., Ltd. Zhejiang Garden Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Garden Pharmaceutical Co., Ltd. is engaged in manufacture pharmaceutical products including Xinnaojian tablets, panaxnotoginseng capsules, sucralfate tablets and Lansoprazole.The company leading product is Xinnaojian traditional chinese tablet, it can be used in the therapy of cardiovascular and cerebrovascular diseases (high blood pressure, hyperlipemia) and cytopenia caused by the teletherapy and chemotherapy of tumor. The company was founded in August, 2001 and is headquartered in Dongyang China.	Health Technology